rethinkTHC Search
Menu
Study breakdown

Male and female mice develop tolerance to THC through different molecular mechanisms

Animal StudyModerate evidence
The takeaway

Disrupting a key cannabinoid receptor desensitization pathway delayed THC tolerance in male mice but had no effect in females, indicating sex-specific mechanisms for how the body adapts to cannabinoids.

Pharmacologists, pain researchers, and clinicians interested in sex differences in cannabinoid therapeutics.

Tolerance mechanism blocked in males had zero effect in females

What the researchers found

The S426A/S430A mutation, which blocks CB1 receptor desensitization via the GRK/beta-arrestin2 pathway, conferred partial resistance to THC tolerance in male mice but did not alter tolerance in female mice. Female mice were also less sensitive to the pain-relieving effects of THC and CP55,940 compared to males.

Why it matters

More women than men use medical cannabis for pain relief, yet tolerance research has been conducted almost exclusively in males. This study reveals that tolerance develops through fundamentally different molecular pathways depending on sex.

The numbers in context

Female mice were markedly less sensitive to the antinociceptive effects of 30 mg/kg THC and 0.3 mg/kg CP55,940 compared to males. The S426A/S430A mutation enhanced the antinociceptive response to both cannabinoids in both sexes.

How the study worked

Male and female S426A/S430A mutant mice and wild-type littermates were tested for antinociceptive and hypothermic responses to repeated dosing with THC and CP55,940, a synthetic cannabinoid.

What this study cannot tell us

Animal study using mice, which may not directly translate to humans. Specific mutation model (S426A/S430A) tests only one desensitization pathway. Pain measurement limited to thermal antinociception.

How to read the evidence

Well-designed animal study using genetic manipulation to test specific molecular mechanisms, but limited to mice.

When this study was published

Published in 2022.

The bigger picture

If tolerance mechanisms differ by sex in mice, they may also differ in humans. This has direct implications for dosing, treatment duration, and expectations about therapeutic benefit in male versus female cannabis patients.

Questions still open

  • What alternative molecular pathway drives THC tolerance in females? Should cannabis dosing recommendations account for sex differences in tolerance development?

Common questions

Do men and women build cannabis tolerance differently?
In mice, disrupting a key receptor pathway delayed THC tolerance in males but not females, suggesting fundamentally different molecular mechanisms for tolerance between sexes.
Are women less responsive to cannabis for pain?
In this mouse study, females were markedly less sensitive to the pain-relieving effects of both THC and a synthetic cannabinoid compared to males.

Read the original research

Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC).

Psychopharmacology, 239(5), 1289-1309

Citation

Henderson-Redmond, Angela N; Sepulveda, Diana E; Ferguson, Erin L; Kline, Aaron M; Piscura, Mary K; Morgan, Daniel J. (2022). Sex-specific mechanisms of tolerance for the cannabinoid agonists CP55,940 and delta-9-tetrahydrocannabinol (Δ9-THC).. Psychopharmacology, 239(5), 1289-1309. https://doi.org/10.1007/s00213-021-05886-9

Explore the wider topic